Proprietary AI analyst is now available
- Public Comps
- Neurones
Neurones Valuation Multiples
Discover revenue and EBITDA valuation multiples for Neurones and similar public comparables like DTS, Tata Teleservices, Birlasoft, Sonaecom and more.
Neurones Overview
About Neurones
Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.
Founded
1984
HQ

Employees
7.1K
Website
Sectors
Financials (LTM)
EV
$624M
Valuation Multiples
Start free trialNeurones Financials
Neurones reported last 12-month revenue of $1B and EBITDA of $113M.
In the same LTM period, Neurones generated $113M in EBITDA and $63M in net income.
Revenue (LTM)
Neurones P&L
In the most recent fiscal year, Neurones reported revenue of $992M and EBITDA of $123M.
Neurones is profitable as of last fiscal year, with gross margin of 63%, EBITDA margin of 12%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Neurones Stock Performance
Neurones has current market cap of $976M, and enterprise value of $624M.
Market Cap Evolution
Neurones' stock price is $40.87.
Neurones share price decreased by 10.1% in the last 30 days, and by 21.2% in the last year.
Neurones has an EPS (earnings per share) of $2.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $624M | $976M | 0.4% | -10.1% | -2.7% | -21.2% | $2.52 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNeurones Valuation Multiples
Neurones trades at 0.6x EV/Revenue multiple, and 5.5x EV/EBITDA.
EV / Revenue (LTM)
Neurones Financial Valuation Multiples
As of June 14, 2026, Neurones has market cap of $976M and EV of $624M.
Neurones has a P/E ratio of 15.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Neurones Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Neurones Margins & Growth Rates
Neurones grew revenue by 5% but EBITDA decreased by 4% in the last fiscal year.
In the most recent fiscal year, Neurones reported gross margin of 63%, EBITDA margin of 12%, and net margin of 6%.
Neurones Margins
Neurones Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Neurones Operational KPIs
Neurones' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Neurones' Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Neurones' Rule of X is 25% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Neurones Competitors
Neurones competitors include DTS, Tata Teleservices, Birlasoft, Sonaecom, Shift, Net263, Systena, Asseco SEE, Data#3 and Quest Holdings.
Most Neurones public comparables operate across IT Consulting.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.0x | 0.9x | 7.7x | - | |||
| 24.3x | - | 21.7x | - | |||
| 1.2x | 1.2x | 7.3x | 7.5x | |||
| 40.1x | - | 15.0x | - | |||
| 1.2x | 1.1x | 8.3x | 7.8x | |||
| 8.2x | - | (37.0x) | - | |||
| 1.4x | 1.2x | 9.4x | - | |||
| 1.7x | 1.6x | 8.4x | 8.2x | |||
This data is available for Pro users. Sign up to see all Neurones competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Neurones
| When was Neurones founded? | Neurones was founded in 1984. |
| Where is Neurones headquartered? | Neurones is headquartered in France. |
| How many employees does Neurones have? | As of today, Neurones has over 7K employees. |
| Who is the CEO of Neurones? | Neurones' CEO is Luc de Chammard. |
| Is Neurones publicly listed? | Yes, Neurones is a public company listed on Euronext Paris. |
| What is the stock symbol of Neurones? | Neurones trades under NRO ticker. |
| When did Neurones go public? | Neurones went public in 2000. |
| Who are competitors of Neurones? | Neurones main competitors include DTS, Tata Teleservices, Birlasoft, Sonaecom, Shift, Net263, Systena, Asseco SEE, Data#3, Quest Holdings. |
| What is the current market cap of Neurones? | Neurones' current market cap is $976M. |
| What is the current revenue of Neurones? | Neurones' last 12 months revenue is $1B. |
| What is the current revenue growth of Neurones? | Neurones revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Neurones? | Current revenue multiple of Neurones is 0.6x. |
| What is the current EBITDA of Neurones? | Neurones' last 12 months EBITDA is $113M. |
| What is Neurones' EBITDA margin? | Neurones' last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Neurones? | Current EBITDA multiple of Neurones is 5.5x. |
| How many companies Neurones has acquired to date? | Neurones hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Neurones has invested to date? | Neurones hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Neurones
Lists including Neurones
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.